Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Revenue

Medigen Vaccine Biologics had revenue of 115.43M TWD in the quarter ending March 31, 2025, with 96.98% growth. This brings the company's revenue in the last twelve months to 662.47M, up 47.80% year-over-year. In the year 2024, Medigen Vaccine Biologics had annual revenue of 605.64M with 55.44% growth.

• Revenue (ttm): 662.47M
• Revenue Growth: +47.80%
• P/S Ratio: 23.67
• Revenue / Employee: 6.43M
• Employees: 103
• Market Cap: 15.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	605.64M	216.01M	55.44%
Dec 31, 2023	389.62M	24.58M	6.73%
Dec 31, 2022	365.04M	-2.92B	-88.87%
Dec 31, 2021	3.28B	3.27B	28,413.03%
Dec 31, 2020	11.51M	10.39M	927.41%